Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Cuprina Holdings (Cayman) LTD

CUPR Clue Score27
Singapore Fiscal year ends December CIK 0001995704
$1.69 -11.05% Close, 9 Oct 2026
Price $1.69 +56.48% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 10 Apr 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2022Revenue0.1Operating income−1.2Net income−1.1EPS, diluted−6.08Fiscal year 2023Revenue0.1 +78.0%Operating income−1.1Net income−1.1EPS, diluted−6.22Fiscal year 2024Revenue0.0 −52.0%Operating income−1.6Net income−1.6EPS, diluted−8.68Fiscal year 2025Revenue0.0 +3.3%Operating income−4.8Net income−4.7EPS, diluted−22.83
FY2022FY2023FY2024FY2025
Revenue 0.1 0.1 0.0 0.0
Growth +78.0% −52.0% +3.3%
Operating income −1.2 −1.1 −1.6 −4.8
Net income −1.1 −1.1 −1.6 −4.7
Growth
EPS, diluted −6.08 −6.22 −8.68 −22.83
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2022Gross margin35.3%Operating margin−2,077.4%Net margin−1,933.8%Free cash flow margin−3,296.4%Fiscal year 2023Gross margin36.3%Operating margin−1,060.1%Net margin−1,111.0%Free cash flow margin−955.6%Fiscal year 2024Gross margin−6.3%Operating margin−3,404.9%Net margin−3,229.5%Free cash flow margin−2,603.1%Fiscal year 2025Gross margin−1.3%Operating margin−9,680.2%Net margin−9,366.8%Free cash flow margin−18,423.4%
FY2022FY2023FY2024FY2025
Gross margin 35.3% 36.3% −6.3% −1.3%
Operating margin −2,077.4% −1,060.1% −3,404.9% −9,680.2%
Net margin −1,933.8% −1,111.0% −3,229.5% −9,366.8%
Free cash flow margin −3,296.4% −955.6% −2,603.1% −18,423.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−1.8Capital expenditure−0.0Free cash flow−1.9Fiscal year 2023Operating cash flow−0.9Capital expenditure−0.1Free cash flow−1.0Fiscal year 2024Operating cash flow−1.2Capital expenditure−0.0Free cash flow−1.3Fiscal year 2025Operating cash flow−9.1Capital expenditure−0.1Free cash flow−9.2
FY2022FY2023FY2024FY2025
Operating cash flow −1.8 −0.9 −1.2 −9.1
Capital expenditure −0.0 −0.1 −0.0 −0.1
Free cash flow −1.9 −1.0 −1.3 −9.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2022Shareholders’ equity−1.8Fiscal year 2023Cash0.0Shareholders’ equity−3.0Fiscal year 2024Cash0.1Total debt0.2Net cash (debt)−0.1Shareholders’ equity−4.5Fiscal year 2025Cash3.1Total debt0.2Net cash (debt)3.0Shareholders’ equity5.1Debt to equity0.03
FY2022FY2023FY2024FY2025
Cash n/a 0.0 0.1 3.1
Total debt n/a n/a 0.2 0.2
Net cash (debt) n/a n/a −0.1 3.0
Shareholders’ equity −1.8 −3.0 −4.5 5.1
Debt to equity n/a n/a n/a 0.03

In millions of SGD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of SGD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
n/a 0.0 0.1 3.1
n/a 0.1 0.0 0.0
n/a 0.0 0.0 n/a
n/a 0.1 0.1 0.1
n/a 1.6 1.7 8.5
Growth +10.0% +387.4%
Liabilities
n/a n/a 0.1 0.0
n/a n/a 0.2 0.1
calc n/a n/a 0.2 0.2
n/a 4.5 6.2 3.4
Equity
n/a −3.0 −4.6 −9.2
−1.8 −3.0 −4.5 5.1
Growth
Per share and net cash
calc n/a n/a −0.1 3.0
n/a n/a n/a 7.4
calc n/a n/a n/a 0.69

Lines marked calc are worked out here from filed figures; point at one for how. Shown in SGD as filed; the screener converts to dollars.